An improper access control vulnerability may allow privilege escalation.This issue affects: * ELI 380 Resting Electrocardiograph: Versions 2.6.0 and prior; * ELI 280/BUR280/MLBUR 280 Resting Electrocardiograph: Versions 2.3.1 and prior; * ELI 250c/BUR 250c Resting Electrocardiograph: Versions 2.1.2 and prior; * ELI 150c/BUR 150c/MLBUR 150c Resting Electrocardiograph: Versions 2.2.0 and prior.
Conclusion & alert: CVE-2022-26389 is rated Low Risk (36.1/100): CVSS High severity, with low exploitation likelihood (EPSS 0.05%). Mandatory action: Monitor for updates and reassess as exploit intelligence or EPSS changes.
Risk is dynamic; we continuously reassess and refresh what is shown on this page as upstream context changes.
EPSS lead: Daily EPSS estimates relative likelihood of exploitation; percentile ranks this CVE among scored vulnerabilities (higher = more severe relative rank).
| # | Date | Old EPSS score | New EPSS score | Delta (New - Old) |
|---|---|---|---|---|
| 1 | 2025-09-03 | 0.04% | 0.05% | +0.01% |
| 2 | 2025-07-06 | 0.06% | 0.04% | -0.02% |
| 3 | 2025-03-19 | — | 0.06% | — |
Full EPSS history (4 records total)
CVSS metrics for this CVE.
| Base score | Version | Severity | Vector | Exploitability | Impact | Score source |
|---|---|---|---|---|---|---|
| 7.7 | 3.1 | HIGH |
|
1.8 | 5.3 | [email protected] |
| Vendor | Product | Version | Raw CPE |
|---|---|---|---|
| No affected products in dataset. | |||